Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer

doi:10.3748/wjg.v23.i41.7407

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8230)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

449

WORD

221

HTML

4718

Figures (1-4)

403

Tables (1-3)

264

Sum=6055

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

865

Download

1310

Sum=2175

Nov 7, 2017 (publication date) through Jan 5, 2025

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 7, 2017; 23(41): 7407-7414
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7407

Table 3 Univariate and multivariate analysis showing factors associated with overall survival

Variable	Univariate		Multivariate
Variable	HR (95%CI)	P value	HR (95%CI)	P value
HER2 status	0.424 (0.208-0.865)	0.018	0.421 (0.206-0.861)	0.018
WD-MD vs PD-SRC	0.694 (0.374-1.290)	0.248
Sex	1.376 (0.821-2.307)	0.226
ECOG PS	2.149 (1.648-2.803)	< 0.001	2.002 (1.530-2.618)	< 0.001
Age (< 65)	1.408 (0.837-2.369)	0.197
Adjuvant chemotherapy	1.750 (0.978-3.128)	0.059

HR: Hazard ratio; CI: Confidence interval; HER2: Human epidermal growth factor receptor 2; WD: Well differentiated; MD: Moderately differentiated; PD: Poorly differentiated; SRC: Signet ring cell carcinoma; ECOG PS: Eastern Cooperative Oncology Group Performance Status.

Citation: Cho JH, Lim JY, Cho JY. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer. World J Gastroenterol 2017; 23(41): 7407-7414
URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7407.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i41.7407